Search research articles
Contact Us
Filters
Showing results (21-30 of 71) with videos related to
Page
of 8
Sort By:
Journal of Cancer Survivorship : Research and Practice
|
September 28, 2022
Racial differences in weight perception among Black and White women diagnosed with breast cancer
Megan C Edmonds, Nina A Bickell, Emily J Gallagher, et al.
Breast Cancer Research and Treatment
|
April 23, 2023
Subjective social status, race, and metabolic syndrome in women with breast cancer
Giampaolo Greco, Nina A Bickell, Sylvia Lin, et al.
JBMR Plus
|
March 1, 2022
Non-Obese MKR Mouse Model of Type 2 Diabetes Reveals Skeletal Alterations in Mineralization and Material Properties
Matthew J L Tice, Stacyann Bailey, Grażyna E Sroga, et al.
Diabetologia
|
June 1, 2016
Non-metabolisable insulin glargine does not promote breast cancer growth in a mouse model of type 2 diabetes
Emily J Gallagher, Zara Zelenko, Aviva Tobin-Hess, et al.
American Journal of Obstetrics and Gynecology
|
June 5, 2020
The midlife transition and the risk of cardiovascular disease and cancer Part I: magnitude and mechanisms
Nathan G Kase, Elissa Gretz Friedman, Michael Brodman, et al.
Endocrinology
|
July 18, 2013
Deletion of growth hormone receptors in postnatal skeletal muscle of male mice does not alter muscle mass and response to pathological injury
Archana Vijayakumar, Nicholas J Buffin, Emily J Gallagher, et al.
Translational Lung Cancer Research
|
January 10, 2022
Assessing the association of diabetes with lung cancer risk
Amanda Leiter, Antonios Charokopos, Stacyann Bailey, et al.
Plos One
|
July 17, 2014
Multi-tissue computational modeling analyzes pathophysiology of type 2 diabetes in MKR mice
Amit Kumar, Thomas Harrelson, Nathan E Lewis, et al.
AACE Clinical Case Reports
|
July 17, 2020
A COMMON PITUITARY AUTOANTIBODY IN TWO PATIENTS WITH IMMUNE CHECKPOINT INHIBITOR-MEDIATED HYPOPHYSITIS: ZCCHC8
Amanda Leiter, Sacha Gnjatic, Mary Fowkes, et al.
Frontiers in Pharmacology
|
September 25, 2024
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) may reduce the risk of developing cancer-related lymphedema following axillary lymph node dissection (ALND)
Stav Brown, Audree B Tadros, Giacomo Montagna, et al.
Page
of 8
Search research articles
Search
Showing results (21-30 of 71) with videos related to
Sort By:
Page
of 8
Journal of Cancer Survivorship : Research and Practice
|
September 28, 2022
Racial differences in weight perception among Black and White women diagnosed with breast cancer
Megan C Edmonds, Nina A Bickell, Emily J Gallagher, et al.
Breast Cancer Research and Treatment
|
April 23, 2023
Subjective social status, race, and metabolic syndrome in women with breast cancer
Giampaolo Greco, Nina A Bickell, Sylvia Lin, et al.
JBMR Plus
|
March 1, 2022
Non-Obese MKR Mouse Model of Type 2 Diabetes Reveals Skeletal Alterations in Mineralization and Material Properties
Matthew J L Tice, Stacyann Bailey, Grażyna E Sroga, et al.
Diabetologia
|
June 1, 2016
Non-metabolisable insulin glargine does not promote breast cancer growth in a mouse model of type 2 diabetes
Emily J Gallagher, Zara Zelenko, Aviva Tobin-Hess, et al.
American Journal of Obstetrics and Gynecology
|
June 5, 2020
The midlife transition and the risk of cardiovascular disease and cancer Part I: magnitude and mechanisms
Nathan G Kase, Elissa Gretz Friedman, Michael Brodman, et al.
Endocrinology
|
July 18, 2013
Deletion of growth hormone receptors in postnatal skeletal muscle of male mice does not alter muscle mass and response to pathological injury
Archana Vijayakumar, Nicholas J Buffin, Emily J Gallagher, et al.
Translational Lung Cancer Research
|
January 10, 2022
Assessing the association of diabetes with lung cancer risk
Amanda Leiter, Antonios Charokopos, Stacyann Bailey, et al.
Plos One
|
July 17, 2014
Multi-tissue computational modeling analyzes pathophysiology of type 2 diabetes in MKR mice
Amit Kumar, Thomas Harrelson, Nathan E Lewis, et al.
AACE Clinical Case Reports
|
July 17, 2020
A COMMON PITUITARY AUTOANTIBODY IN TWO PATIENTS WITH IMMUNE CHECKPOINT INHIBITOR-MEDIATED HYPOPHYSITIS: ZCCHC8
Amanda Leiter, Sacha Gnjatic, Mary Fowkes, et al.
Frontiers in Pharmacology
|
September 25, 2024
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) may reduce the risk of developing cancer-related lymphedema following axillary lymph node dissection (ALND)
Stav Brown, Audree B Tadros, Giacomo Montagna, et al.
Page
of 8